Leif Eriksson is an international expert in next generation computational drug development with 20+ years’ R&D experience, 250+ publications, and 4 patients filed. He is the co-founder of Swedish Pharma, C26 Bioscience, Cell Stress Discoveries, and Santium Pharma. Leif has worked closely with the pharma industry to develop and license molecules for commercialisation.
Cell Stress Discoveries 